Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for can...
CStone Pharmaceuticals has announced that it has received approval to initiate clinical development in C...
Genentech, a member of the Roche Group has announced that the Phase III BLOCKSTONE study, conducted by Shionogi &am...
Saluda Medical Pty Limited ("Saluda Medical") has announced data from two clinical studies evaluating the performance of...
Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines...
Pi Therapeutics, a company dedicated to the development of novel modulators of protein degradation for cancer has announ...
Within the next ten years, up to six new drugs are projected to be approved for the treatment of chronic hepatitis B vir...
The partner of CStone Pharmaceuticals, Agios Pharmaceuticals has announced that the global Phase 3 ClarIDHy trial o...
Takeda Pharmaceutical Company Limited has announced further results from the Phase 3b head-to-head VARSITY study, w...
Growing scientific evidence supports liquid biopsy as a valuable tool for monitoring treatment response in patients with...
Ping An Insurance Company of China has announced that its technology arm, Ping An Technology, has c...
Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, has announced the dosing of a ...
WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring and neuromodulation,...
AstraZeneca announced positive results from the phase III ASCEND trial of Calquence (acalabrutinib) in previously-treate...
Daiichi Sankyo Company, Limited (Daiichi Sankyo) and AstraZeneca have announced positive topline results for the pivotal...
Innovent Biologics and Eli Lilly and Company has jointly announced that IBI301, a recombinant human-mouse...
US based VolitionRx Limited has announced that it has added to its extensive clinical trial programme with the execution...
Asia Pacific is expected to become the destination of choice for clinical trials due to its fast-growing pharmaceutical ...
